[go: up one dir, main page]

HK1023781A1 - Method for producing a correctly folded, biological active recombinant protein. - Google Patents

Method for producing a correctly folded, biological active recombinant protein.

Info

Publication number
HK1023781A1
HK1023781A1 HK00102454A HK00102454A HK1023781A1 HK 1023781 A1 HK1023781 A1 HK 1023781A1 HK 00102454 A HK00102454 A HK 00102454A HK 00102454 A HK00102454 A HK 00102454A HK 1023781 A1 HK1023781 A1 HK 1023781A1
Authority
HK
Hong Kong
Prior art keywords
cells
recombinant protein
producing
biological active
correctly folded
Prior art date
Application number
HK00102454A
Other languages
English (en)
Inventor
Jan-Gunnar Gustafsson
Johan Ohman
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of HK1023781A1 publication Critical patent/HK1023781A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK00102454A 1995-11-13 2000-04-26 Method for producing a correctly folded, biological active recombinant protein. HK1023781A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9504019A SE9504019D0 (sv) 1995-11-13 1995-11-13 Method for production of proteins
PCT/SE1996/001456 WO1997018233A1 (en) 1995-11-13 1996-11-12 Method for producing a correctly folded, biological active recombinant protein

Publications (1)

Publication Number Publication Date
HK1023781A1 true HK1023781A1 (en) 2000-09-22

Family

ID=20400188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00102454A HK1023781A1 (en) 1995-11-13 2000-04-26 Method for producing a correctly folded, biological active recombinant protein.

Country Status (11)

Country Link
US (1) US6605706B1 (sv)
EP (1) EP0952981B1 (sv)
JP (1) JP3930051B2 (sv)
AT (1) ATE261985T1 (sv)
AU (1) AU705192B2 (sv)
CA (1) CA2236751C (sv)
DE (1) DE69631906T2 (sv)
HK (1) HK1023781A1 (sv)
NO (1) NO320175B1 (sv)
SE (1) SE9504019D0 (sv)
WO (1) WO1997018233A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653098B1 (en) * 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
CN1197876C (zh) * 1998-03-31 2005-04-20 通化安泰克生物工程有限公司 含有分子内伴侣样序列的嵌合蛋白及其在胰岛素生产中的应用
GB9913437D0 (en) * 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
FR2820424B1 (fr) * 2001-02-05 2004-01-02 Merieux Oravax Procede de purification de alpa
AR062069A1 (es) 2006-07-14 2008-10-15 Genentech Inc Replegado de proteinas recombinantes
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
WO2022097216A1 (ja) * 2020-11-05 2022-05-12 シミックホールディングス株式会社 組み換えインスリン様成長因子iの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US5231178A (en) 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
EP0600372B1 (de) * 1992-12-02 1997-02-05 Hoechst Aktiengesellschaft Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide

Also Published As

Publication number Publication date
JP2000500023A (ja) 2000-01-11
NO982155D0 (no) 1998-05-12
US6605706B1 (en) 2003-08-12
AU705192B2 (en) 1999-05-20
EP0952981A1 (en) 1999-11-03
AU7659696A (en) 1997-06-05
CA2236751A1 (en) 1997-05-22
NO982155L (no) 1998-05-12
DE69631906D1 (de) 2004-04-22
JP3930051B2 (ja) 2007-06-13
NO320175B1 (no) 2005-11-07
CA2236751C (en) 2007-01-09
DE69631906T2 (de) 2005-01-20
ATE261985T1 (de) 2004-04-15
EP0952981B1 (en) 2004-03-17
WO1997018233A1 (en) 1997-05-22
SE9504019D0 (sv) 1995-11-13

Similar Documents

Publication Publication Date Title
HUP0000317A3 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
WO1989009787A3 (en) Osteogenic devices
IN190327B (sv)
CA2237296A1 (en) Process for the preparation of peptides by way of streptavidin fusion proteins
CA2206399A1 (en) Method for secreting thrombopoietin polypeptides
ATE177472T1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
BG102554A (en) Vectors and methods for gene transfer into cells
DE69632224D1 (de) Reduzierung von Gelation von Fettsäureacylierten Proteinen unter Nutzung von Zitratpuffer
NO950461L (no) Enterisk sammensetning innbefattende naturlig micellært kasein
AU1763288A (en) Production of proteins in active forms
EP0196864A3 (en) Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences
Nakai et al. Amino acid sequence of toxin A from the venom of the Indian cobra (Naja naja)
WO2000034474A3 (en) Growth factor homolog zvegf3
WO2002040697A3 (en) Metabolic rate shifts in fermentations expressing recombinant proteins
HK1023781A1 (en) Method for producing a correctly folded, biological active recombinant protein.
SE8801701D0 (sv) Production technology based on enzymic method
AU1272488A (en) Process for production of physiologically active peptide containing cysteine residue
AR003407A1 (es) Procedimiento de clonacion de un acido nucleico que codifica una proteina con actividad de delta-5,7-esterol, delta-7-reductasa, procedimiento de preparacion de la proteina, procemiento de reduccion in vitro de un esterol insaturado, procedimiento de produccion de pregnenolona, cepa de levadura transformada y metodo de diagnostico in vitro para la deteccion de la deficiencia de delta-5, 7-esterol, delta-7-reductasa
KR910021477A (ko) 인체 단백질 c의 글리코실화 돌연변이체의 발현을 위한 벡터 및 화합물
AU4114596A (en) A process of producing extracellular proteins in bacteria
DE3877035D1 (de) Gentechnologisches verfahren zur herstellung von polypeptiden.
Ong et al. Analysis of proteins from different phase variants of the entomopathogenic bacteria Photorhabdus luminescens by two‐dimensional zymography
EP0876610A4 (en) METHOD FOR INCREASING OR REDUCING FERTILITY BY USE OF A POLYPEPTIDE IN THE SPERME-UF BOND
CA2168382A1 (en) Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine
CA2241367A1 (en) Vector for expression of n-terminally extended proteins in yeast cell

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091112